BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 7541723)

  • 1. Migration of human polymorphonuclear leukocytes through a synovial fibroblast barrier is mediated by both beta 2 (CD11/CD18) integrins and the beta 1 (CD29) integrins VLA-5 and VLA-6.
    Gao JX; Wilkins J; Issekutz AC
    Cell Immunol; 1995 Jul; 163(2):178-86. PubMed ID: 7541723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leucocyte migration through human dermal fibroblast monolayers is dependent on both beta 2-integrin (CD11/CD18) and beta 1-integrin (CD29) mechanisms.
    Gao JX; Issekutz AC
    Immunology; 1995 Jul; 85(3):485-94. PubMed ID: 7558139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: role for CD11/CD18, very late antigen-4 (CD49d/CD29), very late antigen-5 (CD49e/CD29), and vascular cell adhesion molecule-1 (CD106).
    Shang XZ; Lang BJ; Issekutz AC
    J Immunol; 1998 Jan; 160(1):467-74. PubMed ID: 9552005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes.
    Chuluyan HE; Issekutz AC
    J Clin Invest; 1993 Dec; 92(6):2768-77. PubMed ID: 7902847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta 1 integrin, very late activation antigen-4 on human neutrophils can contribute to neutrophil migration through connective tissue fibroblast barriers.
    Gao JX; Issekutz AC
    Immunology; 1997 Mar; 90(3):448-54. PubMed ID: 9155654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration.
    Chuluyan HE; Osborn L; Lobb R; Issekutz AC
    J Immunol; 1995 Sep; 155(6):3135-4. PubMed ID: 7545712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2 (CD18) and beta 1 (CD29) integrin mechanisms in migration of human polymorphonuclear leucocytes and monocytes through lung fibroblast barriers: shared and distinct mechanisms.
    Shang XZ; Issekutz AC
    Immunology; 1997 Dec; 92(4):527-35. PubMed ID: 9497495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mac-1 (CD11b/CD18) is the predominant beta 2 (CD18) integrin mediating human neutrophil migration through synovial and dermal fibroblast barriers.
    Gao JX; Issekutz AC
    Immunology; 1996 Jul; 88(3):463-70. PubMed ID: 8774366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms.
    Issekutz AC; Chuluyan HE; Lopes N
    J Leukoc Biol; 1995 Apr; 57(4):553-61. PubMed ID: 7722414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha9beta1 integrin is expressed on human neutrophils and contributes to neutrophil migration through human lung and synovial fibroblast barriers.
    Shang T; Yednock T; Issekutz AC
    J Leukoc Biol; 1999 Nov; 66(5):809-16. PubMed ID: 10577513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium.
    Meerschaert J; Furie MB
    J Immunol; 1995 Apr; 154(8):4099-112. PubMed ID: 7535821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.
    Issekutz AC; Lopes N
    Immunology; 1993 Aug; 79(4):600-7. PubMed ID: 8104889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood monocyte migration to acute lung inflammation involves both CD11/CD18 and very late activation antigen-4-dependent and independent pathways.
    Li XC; Miyasaka M; Issekutz TB
    J Immunol; 1998 Dec; 161(11):6258-64. PubMed ID: 9834114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation.
    Burns JA; Issekutz TB; Yagita H; Issekutz AC
    J Immunol; 2001 Apr; 166(7):4644-9. PubMed ID: 11254723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of LFA-1 (CD11a/CD18) and MAC-1 (CD11b/CD18) to the in vivo migration of polymorphonuclear leucocytes to inflammatory reactions in the rat.
    Issekutz AC; Issekutz TB
    Immunology; 1992 Aug; 76(4):655-61. PubMed ID: 1398754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro.
    Meerschaert J; Furie MB
    J Immunol; 1994 Feb; 152(4):1915-26. PubMed ID: 7509831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers.
    Shang XZ; Issekutz AC
    Eur J Immunol; 1998 Jun; 28(6):1970-9. PubMed ID: 9645379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecules mediating neutrophil migration to arthritis in vivo and across endothelium and connective tissue barriers in vitro.
    Issekutz AC
    Inflamm Res; 1998 Oct; 47 Suppl 3():S123-32. PubMed ID: 9831314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1.
    Chuluyan HE; Schall TJ; Yoshimura T; Issekutz AC
    J Leukoc Biol; 1995 Jul; 58(1):71-9. PubMed ID: 7542307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-selectin (endothelial-leukocyte adhesion molecule-1) is not required for the migration of neutrophils across IL-1-stimulated endothelium in vitro.
    Furie MB; Burns MJ; Tancinco MC; Benjamin CD; Lobb RR
    J Immunol; 1992 Apr; 148(8):2395-404. PubMed ID: 1373167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.